Symptomtext
mistakenly gave (2) injections with no reported adverse event; Initial information received on 06-Sep-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 69-year-old female patient who mistakenly taken (2) injections with no reported adverse event while receiving vaccine Influenza Quadrival A-B High Dose HV Vaccine [Fluzone High-Dose Quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) and SHINGLES VACCINE for Prophylactic vaccination. On 06-Sep-2023, the patient received a dose and strength of 0.7 ml (Frequency = once) suspect Influenza Quadrival A-B High Dose HV vaccine injection (lot: UT8079AA, Expiry date: 30-Jun-2024) via intramuscular route in the left deltoid for Immunization and patient had mistakenly (2) injections with no reported adverse event (extra dose administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Additional information was received on 06-Sep-2023 from a physician. Concomitant medication (SHINGRIX) added, CO updated, however no significant information received, text amended accordingly.